GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NovoCure Ltd (STU:038) » Definitions » Inventories, Raw Materials & Components

NovoCure (STU:038) Inventories, Raw Materials & Components : €9.4 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is NovoCure Inventories, Raw Materials & Components?

NovoCure's inventories, raw materials & components for the quarter that ended in Mar. 2024 was €9.4 Mil.

NovoCure's quarterly raw materials declined from Sep. 2023 (€9.7 Mil) to Dec. 2023 (€9.4 Mil) and declined from Dec. 2023 (€9.4 Mil) to Mar. 2024 (€9.4 Mil).

NovoCure's annual raw materials increased from Dec. 2021 (€1.3 Mil) to Dec. 2022 (€4.1 Mil) and increased from Dec. 2022 (€4.1 Mil) to Dec. 2023 (€9.4 Mil).


NovoCure Inventories, Raw Materials & Components Historical Data

The historical data trend for NovoCure's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovoCure Inventories, Raw Materials & Components Chart

NovoCure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.52 4.25 1.31 4.07 9.41

NovoCure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.29 5.94 9.73 9.41 9.36

NovoCure Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


NovoCure (STU:038) Business Description

Industry
Traded in Other Exchanges
Address
Grenville Street, No. 4 The Forum, Second Floor, St. Helier, JEY, JE2 4UF
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. Products are comprised of two main components: electric field generator and arrays and related accessories. NovoCure derives its major revenues in the United States.

NovoCure (STU:038) Headlines

No Headlines